Literature DB >> 26676754

Novel Morphologic and Genetic Analysis of Cancer Cells in a 3D Microenvironment Identifies STAT3 as a Regulator of Tumor Permeability Barrier Function.

Min Chul Park1, Hyobin Jeong2, Sung Hwa Son3, YounHa Kim4, Daeyoung Han4, Peter C Goughnour4, Taehee Kang3, Nam Hoon Kwon3, Hyo Eun Moon5, Sun Ha Paek5, Daehee Hwang6, Ho Jun Seol7, Do-Hyun Nam7, Sunghoon Kim8.   

Abstract

Tumor permeability is a critical determinant of drug delivery and sensitivity, but systematic methods to identify factors that perform permeability barrier functions in the tumor microenvironment are not yet available. Multicellular tumor spheroids have become tractable in vitro models to study the impact of a three-dimensional (3D) environment on cellular behavior. In this study, we characterized the spheroid-forming potential of cancer cells and correlated the resulting spheroid morphologies with genetic information to identify conserved cellular processes associated with spheroid structure. Spheroids generated from 100 different cancer cell lines were classified into four distinct groups based on morphology. In particular, round and compact spheroids exhibited highly hypoxic inner cores and permeability barriers against anticancer drugs. Through systematic and correlative analysis, we reveal JAK-STAT signaling as one of the signature pathways activated in round spheroids. Accordingly, STAT3 inhibition in spheroids generated from the established cancer cells and primary glioblastoma patient-derived cells altered the rounded morphology and increased drug sensitivity. Furthermore, combined administration of the STAT3 inhibitor and 5-fluorouracil to a mouse xenograft model markedly reduced tumor growth compared with monotherapy. Collectively, our findings demonstrate the ability to integrate 3D culture and genetic profiling to determine the factors underlying the integrity of the permeability barrier in the tumor microenvironment, and may help to identify and exploit novel mechanisms of drug resistance. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26676754     DOI: 10.1158/0008-5472.CAN-14-2611

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Biocon's target factory.

Authors:  Thomas X Neenan; Robert E Burrier; Sunghoon Kim
Journal:  Nat Biotechnol       Date:  2018-09-06       Impact factor: 54.908

2.  Photothermal therapy of glioblastoma multiforme using multiwalled carbon nanotubes optimized for diffusion in extracellular space.

Authors:  Brittany N Eldridge; Brian W Bernish; Cale D Fahrenholtz; Ravi Singh
Journal:  ACS Biomater Sci Eng       Date:  2016-05-09

3.  P-Glycoprotein-Targeted Photothermal Therapy of Drug-Resistant Cancer Cells Using Antibody-Conjugated Carbon Nanotubes.

Authors:  Xubin Suo; Brittany N Eldridge; Han Zhang; Chengqiong Mao; Yuanzeng Min; Yao Sun; Ravi Singh; Xin Ming
Journal:  ACS Appl Mater Interfaces       Date:  2018-09-18       Impact factor: 9.229

Review 4.  Emerging Paradigm of Crosstalk between Autophagy and the Ubiquitin-Proteasome System.

Authors:  Taewook Nam; Jong Hyun Han; Sushil Devkota; Han-Woong Lee
Journal:  Mol Cells       Date:  2017-12-12       Impact factor: 5.034

5.  Constitutive Activation of STAT3 in Myeloma Cells Cultured in a Three-Dimensional, Reconstructed Bone Marrow Model.

Authors:  Yung-Hsing Huang; Ommoleila Molavi; Abdulraheem Alshareef; Moinul Haque; Qian Wang; Michael P Chu; Christopher P Venner; Irwindeep Sandhu; Anthea C Peters; Afsaneh Lavasanifar; Raymond Lai
Journal:  Cancers (Basel)       Date:  2018-06-16       Impact factor: 6.639

6.  STAT3 is activated in multicellular spheroids of colon carcinoma cells and mediates expression of IRF9 and interferon stimulated genes.

Authors:  Elin Edsbäcker; Jason T Serviss; Iryna Kolosenko; Caroline Palm-Apergi; Angelo De Milito; Katja Pokrovskaja Tamm
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

7.  A Novel High-Throughput 3D Screening System for EMT Inhibitors: A Pilot Screening Discovered the EMT Inhibitory Activity of CDK2 Inhibitor SU9516.

Authors:  Kazuya Arai; Takanori Eguchi; M Mamunur Rahman; Ruriko Sakamoto; Norio Masuda; Tetsuya Nakatsura; Stuart K Calderwood; Ken-Ichi Kozaki; Manabu Itoh
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

8.  Functional characterization of EI24-induced autophagy in the degradation of RING-domain E3 ligases.

Authors:  Sushil Devkota; Hyobin Jeong; Yunmi Kim; Muhammad Ali; Jae-Il Roh; Daehee Hwang; Han-Woong Lee
Journal:  Autophagy       Date:  2016-08-19       Impact factor: 16.016

9.  Characterization of Mutational Status, Spheroid Formation, and Drug Response of a New Genomically-Stable Human Ovarian Clear Cell Carcinoma Cell Line, 105C.

Authors:  Bart Kolendowski; Yudith Ramos Valdes; Hal Hirte; Hiroaki Itamochi; Wonjae Lee; Mark Carey; Trevor G Shepherd; Gabriel E DiMattia
Journal:  Cells       Date:  2020-11-03       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.